Ocugen Seeks To Sell 100 Million Indian Vaccine Doses In U.S. In 2021
Ocugen Inc seeks to sell 100 million doses of India's statebacked COVID19 vaccine COVAXIN in the United States this year, the U.S. firm's chief executive Shankar Musunuri told Reuters on Monday.source https://www.news18.com/news/india/ocugen-seeks-to-sell-100-million-indian-vaccine-doses-in-u-s-in-2021-3537953.html
No comments